首页 > 市场调查报告书 > 医疗设备

麻醉

市场调查报告书

商品编码

1904818

吸入麻醉剂市场规模、份额及成长分析（按药物、应用和地区划分）－2026-2033年产业预测

Inhalation Anesthesia Market Size, Share, and Growth Analysis, By Drug (Sevoflurane, Desflurane), By End-Use (Hospitals, Ambulatory Surgical Centers), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 200 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，吸入麻醉剂市场规模将达到 17.5 亿美元，到 2025 年将达到 19.1 亿美元，到 2033 年将达到 39.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 9.4%。

吸入麻醉市场预计将迎来显着成长，这主要得益于慢性病盛行率上升和医疗机构需求不断增长。全球外科手术数量的激增进一步推动了这一增长，凸显了对吸入麻醉解决方案的持续需求。麻醉剂研发的技术进步以及对创新技术投资的不断增加，为市场参与者开闢了新的机会。此外，人口老化和对儿童专业麻醉需求的不断增长预计将推动市场的长期扩张。然而，潜在的健康风险、合格麻醉医师的短缺以及先进麻醉输送系统的高成本等挑战，可能会抑制未来对吸入麻醉产品的需求。

吸入麻醉市场驱动因素

随着全球手术数量的增加，慢性疾病的增加推动了对吸入麻醉的需求。手术介入日益频繁，麻醉在确保患者术中安全和舒适方面发挥着至关重要的作用，这将为市场带来新的成长机会。对有效麻醉解决方案日益增长的需求表明，随着医疗机构致力于改善手术效果和整体患者照护，吸入麻醉具有巨大的成长潜力。因此，吸入麻醉有望吸引更多关注，从而为市场发展创造有利环境。

吸入麻醉市场的限制

接受过吸入麻醉训练的麻醉医师数量有限，某些地区的短缺情况可能更为严重。缺乏能有效实施吸入麻醉的合格人员，对市场成长前景构成重大挑战。随着麻醉服务需求的持续增长，熟练医务人员的短缺可能会阻碍市场的发展和扩张。解决这个人才短缺问题对于充分发挥吸入麻醉的创新和广泛应用潜力至关重要，最终有助于避免对市场动态负面影响。

吸入麻醉市场趋势

随着医疗机构日益重视环保实践，对永续麻醉剂的需求不断增长，正推动吸入麻醉剂市场持续成长。为此，製造商正积极创新，研发对环境影响最小的麻醉剂，以回应全球永续性倡议。这项转变不仅符合监管要求，也吸引了致力于减少碳足迹的医疗机构的注意。随着医疗机构环保意识的不断增强，投资永续解决方案的公司有望在市场中脱颖而出，获得竞争优势，同时兼顾病患安全和环境保护的双重目标。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Baxter International Inc.（USA）
Halocarbon Products Corporation（USA）
Piramal Critical Care（India）
AbbVie Inc.（USA）
Fresenius Kabi AG（Germany）
GE Healthcare（USA）
Hikma Pharmaceuticals PLC（UK）
Linde Plc（Ireland）
Dragerwerk AG & Co. KGaA（Germany）
Mindray Medical International Limited（China）
Shenzhen Landwind Industry Co., Ltd.（China）
Medtronic Plc（Ireland）
Medtronic Plc（Ireland）
Smith's Group plc（UK）
Teleflex Incorporated（USA）
Masimo Corporation（USA）
Penlon Ltd.（UK）
Dameca A/S（Denmark）
Soma Technology, Inc.（USA）
Narang Medical Limited（India）

简介目录

Product Code: SQMIG35B2217

Inhalation Anesthesia Market size was valued at USD 1.75 Billion in 2024 and is poised to grow from USD 1.91 Billion in 2025 to USD 3.93 Billion by 2033, growing at a CAGR of 9.4% during the forecast period (2026-2033).

The inhalation anesthesia market is poised for significant growth driven by the rising prevalence of chronic diseases and increased demand within healthcare facilities. This growth is further fueled by a surge in surgical procedures globally, highlighting a consistent need for inhalation anesthesia solutions. Technological advancements in anesthetic development and expanded investments in innovative techniques are opening new avenues for market players. Additionally, an aging population and the increasing need for specialized pediatric anesthesia are expected to enhance market expansion over time. However, challenges such as potential health risks, a shortage of qualified anesthesiologists, and the high costs associated with advanced anesthesia delivery systems may dampen future demand for inhalation anesthesia products.

Top-down and bottom-up approaches were used to estimate and validate the size of the Inhalation Anesthesia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Inhalation Anesthesia Market Segments Analysis

Global Inhalation Anesthesia Market is segmented by Drug, Application End Use and region. Based on Drug, the market is segmented into Sevoflurane, Desflurane, Isoflurane, and Others. Based on Application, the market is segmented into Induction, and Maintenance. Based on End-Use, the market is segmented into Hospitals,Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Inhalation Anesthesia Market

The increasing prevalence of chronic diseases has led to a rise in surgical procedures globally, driving the demand for inhalation anesthesia. As surgical interventions become more frequent, the essential function of anesthesia in ensuring patient safety and comfort during these procedures will open up new avenues for growth within the market. This heightened need for effective anesthetic solutions signifies a robust expansion potential for inhalation anesthesia, as healthcare providers seek to enhance surgical outcomes and improve overall patient care. Consequently, the spotlight on inhalation anesthesia will likely intensify, creating favorable conditions for market advancements.

Restraints in the Inhalation Anesthesia Market

The availability of trained anesthesiologists specializing in the administration of inhalation anesthesia is limited, and in certain regions, this shortage may be worsening. The lack of qualified professionals capable of effectively managing inhalation anesthesia poses a significant challenge to the market's growth prospects. As the demand for anesthesia services continues to rise, the insufficient pool of skilled practitioners could hinder advancements and expansion within the market. Addressing this workforce gap is essential to ensure that the potential for innovation and broader application of inhalation anesthesia is fully realized, ultimately impacting overall market dynamics negatively.

Market Trends of the Inhalation Anesthesia Market

The inhalation anesthesia market is increasingly driven by a growing demand for sustainable anesthetic agents, as healthcare providers prioritize environmentally friendly practices. Manufacturers are responding by innovating and formulating anesthetics that have minimal ecological impact, aligning with global sustainability initiatives. This shift not only meets the regulatory requirements but also appeals to institutions committed to reducing their carbon footprint. As eco-consciousness continues to gain traction in medical settings, companies that invest in sustainable solutions are poised to differentiate themselves and gain a competitive edge in the market, catering to the dual objectives of patient safety and environmental stewardship.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Case Study Analysis
Regulatory Landscape
Technology Analysis

Inhalation Anesthesia Market, By Drug

Market Overview
Sevoflurane
Desflurane
Isoflurane
Others

Inhalation Anesthesia Market, By Application

Market Overview
Induction
Maintenance

Inhalation Anesthesia Market, By End-Use

Market Overview
Hospitals
Ambulatory Surgical Centers
Others

Healthcare Analytical Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Baxter International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Halocarbon Products Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Piramal Critical Care (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hikma Pharmaceuticals PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Linde Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray Medical International Limited (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Landwind Industry Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith's Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Masimo Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penlon Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dameca A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soma Technology, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Narang Medical Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments